Honokiol (Magnolia Extract)
Honokiol is a bioactive compound extracted from the bark, seed cones, and leaves of trees belonging to the Magnolia genus. This natural compound has been used for centuries in traditional Chinese and Japanese medicine, primarily for its calming and anti-anxiety properties. In recent years, scientific research has begun to uncover a wide array of potential health benefits associated with honokiol, making it a subject of growing interest in the fields of pharmacology and integrative medicine.
Chemical Composition and Properties
Honokiol is a type of polyphenol, specifically a biphenolic compound, which means it consists of two phenol groups. Its chemical structure allows it to easily cross the blood-brain barrier, making it particularly effective in exerting its effects on the central nervous system. This property is one of the reasons why honokiol is often studied for its neuroprotective and anxiolytic (anxiety-reducing) effects.
Health Benefits
1. Anti-Anxiety and Sedative Effects
One of the most well-documented uses of honokiol is its ability to reduce anxiety and promote relaxation. Studies have shown that honokiol can modulate the activity of gamma-aminobutyric acid (GABA) receptors in the brain, which play a crucial role in regulating mood and anxiety levels. By enhancing GABAergic activity, honokiol can produce a calming effect without the sedative side effects commonly associated with pharmaceutical anxiolytics.
2. Neuroprotective Properties
Honokiol has shown promise in protecting the brain from various forms of damage. Research indicates that it can reduce oxidative stress and inflammation, both of which are key factors in the development of neurodegenerative diseases like Alzheimer's and Parkinson's. Additionally, honokiol has been found to promote the growth of new neurons, a process known as neurogenesis, which could have implications for cognitive health and recovery from brain injuries.
3. Anti-Cancer Potential
Emerging research suggests that honokiol may have anti-cancer properties. It has been shown to inhibit the growth of various cancer cell lines, including breast, lung, and prostate cancers. The mechanisms behind its anti-cancer effects are thought to include the induction of apoptosis (programmed cell death) in cancer cells, inhibition of angiogenesis (formation of new blood vessels that feed tumors), and suppression of metastasis (spread of cancer to other parts of the body).
4. Anti-Inflammatory and Antioxidant Effects
Honokiol exhibits strong anti-inflammatory and antioxidant properties. It can inhibit the production of pro-inflammatory cytokines and reduce the activity of nuclear factor-kappa B (NF-κB), a protein complex that plays a key role in regulating the immune response to infection. By mitigating inflammation and oxidative stress, honokiol may help manage chronic inflammatory conditions such as arthritis and cardiovascular diseases.
5. Cardiovascular Health
Preliminary studies suggest that honokiol may benefit cardiovascular health by improving blood flow and reducing blood pressure. Its antioxidant properties help protect the vascular endothelium (the inner lining of blood vessels) from oxidative damage, which is a contributing factor in the development of atherosclerosis (hardening of the arteries).
Safety and Dosage
While honokiol is generally considered safe, it is important to consult with a healthcare provider before starting any new supplement, especially for individuals who are pregnant, nursing, or taking other medications. The appropriate dosage of honokiol can vary depending on the form of the supplement and the specific health condition being targeted. Commonly, honokiol supplements are available in capsule or powder form, with typical dosages ranging from 200 to 500 mg per day.
Articles/Studies
Anxiolytic activity
In rat brain membranes, honokiol and magnolol at a concentration of 5.0 μM, enhanced binding of [3H]muscimol and [3H]flunitrazepam to the ꝩ-aminobutyric acid receptor, but honokiol was 2.5 to 5.2 times more potent than magnolol. Honokiol and magnolol also enhanced the potentiating effect of 200 nM ꝩ-aminobutyric acid on [3H]flunitrazepam binding with EC50 values of 0.61 μM and 1.6 μM. Honokiol and magnolol increased [3H]muscimol binding by approximately 68% with EC50 values of 2.3 and 12.0 μM, respectively.
In elevated plus-maze tests, treatment of mice with honokiol prolonged the time spent in the open arms, showing an anxiolytic effect. Seven daily treatments with 0.1–1 mg/kg bw honokiol, demonstrated an anxiolytic effect with the optimal dose at 0.2 mg/kg bw. These results suggest that honokiol is the chemical responsible for the anxiolytic effect
of the water extract of the bark in vivo. (WHO-VOL4 pg 173)
Alzheimer's
- Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer’s disease via regulating beta-secretase activity.
- This study suggests potential anti-amyloidogenic properties of magnolol and honokiol and their structure related derivatives.
- Honokiol attenuates AβO-induced learning and memory dysfunction in mice and it may be a potential candidate in Alzheimer's disease therapy.
Antibacterial / Antimicrobial / Antifungal
- Magnolol and honokiol are potentially useful for the treatment of drug-resistant S. aureus infections when used in combination with lower concentration of antibiotics.
- Magnolol and honokiol showed a broad spectrum of synergistic potentiation of conventional antibacterial agents.
- Antimicrobial effect of Magnolia officinalis extract against Staphylococcus aureus
- Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis
- Honokiol reduces fungal burden and ameliorate inflammation lesions of Aspergillus fumigatus keratitis.
Anti-Inflammatory
Antioxidant
Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA.
Antiviral
- Honokiol could be a potential new candidate for clinical consideration in the treatment of HSV-1 infection.
- Dengue: Honokiol inhibits the replication, viral gene expression, and endocytotic process of DENV-2, making it a promising agent for chemotherapy of DENV infection.
Cancer
- Honokiol, a multifunctional antiangiogenic and antitumor agent.
- Honokiol suppresses cell proliferation and tumor migration through ROS in human anaplastic thyroid cancer cells.
- Honokiol combined with curcumin sensitizes multidrug-resistant human lung adenocarcinoma A549/DDP cells to cisplatin.
- Mechanism of apoptotic induction on T24 cells by honokiol and its synergistic anticancer effect in combination with hydroxycamptothecin.
- Natural lignans honokiol and magnolol as potential anticarcinogenic and anticancer agents.
- Honokiol can inhibit the proliferation and migration and induce apoptosis of CAL-27 cells.
- Anti‑proliferative effect of honokiol on SW620 cells.
- Honokiol inhibits growth and the progression of cancers of different organs.
- Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis.
- Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.
- Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo
- Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells
- Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
- Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore
- Evaluation of anticancer activity of honokiol by complexation with hydroxypropyl-β-cyclodextrin.
- Honokiol potentiates apoptosis, suppresses **osteoclastogenesis,** and inhibits invasion through modulation of nuclear factor-kappaB activation pathway
- Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis.
Bladder Cancer
Brain Cancer
Breast Cancer
- Honokiol sensitizes breast cancer cells to TNF-alpha induction of apoptosis by inhibiting Nur77 expression.
- Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol
- Honokiol inhibits breast cancer cell metastasis.
- Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.
- Comprehensive computational analysis of honokiol targets for cell cycle inhibition and immunotherapy in metastatic breast cancer stem cells.
- Honokiol inhibits the growth of hormone-resistant breast cancer cells.
Colon / Colorectal Cancer
- "Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells."
- Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO
Drug Resistant Cancer
- Two case reports of intravenous honokiol in drug-resistant cancer.
- Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
Gastric Cancer
Glioblastoma
- Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis
- Honokiol in glioblastoma recurrence: a case report.
Hepatocellular / Liver Cancer
Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
Kidney Cancer
Leukemia
- The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
- Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells
- Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia.
- Honokiol is a potent inducer of apoptosis in B-CLL cells. (B cell Leukemia)
- Honokiol-chlorambucil co-prodrugs selectively enhance the killing effect through STAT3 binding on lymphocytic leukemia cells.
- Honokiol induces ferroptosis by upregulating HMOX1 in acute myeloid leukemia cells.
Lung Cancer
- Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
- Honokiol is a promising candidate to suppress the development and even progression of lung tumors driven by EGFR deregulation.
- Synergistic killing effect of paclitaxel and honokiol in **non-small cell lung cancer** cells through paraptosis induction.
- Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells
- Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
- Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells.
- Honokiol inhibits EMT-mediated motility and migration of human NSCLC cells in vitro.
- Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer.
Lymph Node Metastasis
- A compound found within magnolia inhibits lymph node cancer metastasis in an animal model.
- Honokiol causes considerable induction of apoptosis in lymphoid malignant cells, both in vitro and in vivo.
Melanoma
- Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
- Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells
- This study revealed a novel epigenetic mechanism of magnolol-induced cell death in melanoma.
Neuroblastoma
- Honokiol has the potential to be a therapeutic option for neuroblastomas.
- Honokiol has potential for treating neuroblastomas.
Oral Cancer
- Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
- Honokiol and 5-FU exert a synergistic therapeutic effect on oral squamous cell carcinoma by inducing apoptosis.
- Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I
- Dietary supplement Magnolia officinalis extract could be used for the prevention against oral carcinoma.
Ovarian Cancer
- Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells.
- Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
- Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2.
Pancreatic Cancer
Prostate Cancer
- Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
- c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
Used with Chemotherapy Drugs
- Honokiol and 5-FU exert a synergistic therapeutic effect on oral squamous cell carcinoma by inducing apoptosis.
- Counteracting cisplatin-induced testicular damages by natural polyphenol constituent honokiol.
Cardiovascular
- Honokiol exhibits a protective effect gainst oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
- Honokiol inhibits vascular smooth muscle cell proliferation, indicating it may have a role in arteriosclerosis treatment.
- Honokiol post-treatment ameliorates myocardial ischemia/reperfusion injury.
- Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress.
- Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation.
- Honokiol ameliorates post-myocardial infarction heart failure.
Cognitive Effects
- Honokiol could improve cognitive function in epilepsy mice.
- Honokiol attenuates the memory impairments, oxidative stress, neuroinflammation, and GSK-3β activation in vascular dementia rats.
- Mitigation of honokiol on fluoride-induced mitochondrial oxidative stress, mitochondrial dysfunction, and cognitive deficits.
COVID-19
Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection.
Diabetes
- Honokiol can protect against type 2 diabetes by improving insulin resistance, glucose and lipid metabolism, and inflammation.
- Honokiol improves endothelial function in type 2 diabetes.
- Honokiol alleviates diabetic nephropathy pathogenesis possibly by attenuating ER stress and Rock pathway.
Fungal Infection
- Honokiol reduces fungal load and inflammatory cytokines in aspergillus fumigatus keratitis.
- Honokiol reduces fungal burden and ameliorate inflammation lesions of Aspergillus fumigatus keratitis.
Gastrointestinal Effects
- The therapeutic effects of Magnolia officinalis extraction on an antibiotics-induced intestinal dysbacteriosis.
- Sirtuin-3 stimulation by honokiol prevented and reversed NSAID-induced gastric injury.
- Honokiol alleviates inflammatory bowel disease by improving endothelial permeability through TRPV4.
Hepatoprotective
- Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes.
- Apoptotic and antihepatofibrotic effect of honokiol via activation of GSK3β and suppression of Wnt/β-catenin pathway in hepatic stellate cells.
- Honokiol acts as a potent anti-fibrotic agent in the liver.
- Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy
- Honokiol inhibits the inflammatory response and lipid metabolism disorder by inhibiting p38α in alcoholic liver disease.
- Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome.
Immune System Effects
Liver Effects
- Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
- Honokiol alleviates acetaminophen-induced hepatotoxicity.
Menopause
Neuroprotective / Neurological Effects
- The present work summarizes what is currently known concerning the neuroprotective effects of honokiol.
- A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect.
- Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.
- Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice
- The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors
- Honokiol exerts protective effects on neural myelin sheaths after compressed spinal cord injury.
- Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
- Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures
- Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects.
- Honokiol proves to be a potential candidate for cellular therapeutics against neurodegenerative disorders.
Pancreatitis
Honokiol prevents intestinal barrier dysfunction in mice with severe acute pancreatitis.
Peridontal Disease
- Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms
- Honokiol may be a promising compound to alleviate the progression of oral fibrogenesis.
Renoprotective
Honokiol protects the kidney from renal ischemia and reperfusion injury.
Sepsis
- Honokiol alleviates sepsis-induced acute kidney injury.
- These findings suggest that honokiol plays its protective role on sepsis-associated acute kidney injury against oxidative stress and inflammatory signals.
Stress
Traumatic Brain Injury
Weight Control
- Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial
- Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes
- Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
Other Effects
- Honokiol is a potent scavenger of superoxide and peroxyl radicals.
- Effects of honokiol and magnolol on acetylcholine release from rat hippocampal slices.
- Magnolia officinalis Extract Contains Potent Inhibitors against PTP1B and Attenuates Hyperglycemia in db/db Mice
- Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol.
- Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats
- Honokiol and magnolol increase the number of {3H} muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites.
- Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects?
- Honokiol: A non-adipogenic PPARγ agonist from nature.
- Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage.
- Honokiol improved cell survival and chondrogenesis of hUC-MSCs and inhibited IL-1β-induced inflammatory response.
- The results revealed that honokiol can alleviate autophagy and pulmonary arterial hypertension.
- Honokiol suppresses 2,6-dinitrochlorobenzene-induced atopic dermatitis.